Educational material on tuberculosis

Interactive e-learning content

Guidelines

Tuberculosis management in Europe
G.B. Migliori, M.C. Raviglione, T. Schaberg, et al.
Eur Respir J 1999; 14: 978-992
PDF journal article, handout or slides
PDF journal article, handout or slides
Recommended standards for modern tuberculosis laboratory services in Europe
F.A. Drobniewski, S. Hoffner, S. Rusch-Gerdes, et al.
Eur Respir J 2006; 28: 903-909
PDF journal article, handout or slides
PDF journal article, handout or slides

CME tests

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova
Jenkins Helen E., Crudu Valeriu, Soltan Viorel, Ciobanu Ana, Domente Liliana, Cohen Ted
Eur Respir J 2014; 43: 1132-1141
Congress or journal article abstractFull text journal articlePDF journal article, handout or slidesCME test or case report
Congress or journal article abstractFull text journal articlePDF journal article, handout or slidesCME test or case report
Black lungs and tuberculosis
A Aujayeb, S. Worthy, C. Stenton (Newcastle upon Tyne, United Kingdom)

Breathe 2012; 8: 247-251
CME test or case report
CME test or case report

Webcasts

IP-10 decreases during antituberculous treatment in children with active tuberculosis.
A. Strzelak (Warszawa, Poland), A. Komorowska-Piotrowska (Warszawa, Poland), A. Borowa (Otwock, Poland), M. Krasinska (Otwock, Poland), W. Feleszko (Warszawa, Poland), M. Kulus (Warszawa, Poland)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Role of N-acetylcysteine(NAC) in preventing development of anti tuberculosis therapy(ATT) induced liver injury in pulmonary tuberculosis(PTB) patients, a simple randomized single blind clinical trial
S. Ahmed (Karachi, Pakistan), N. Ahmed Rao (Karachi, Pakistan)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Mortality and associated factors among drug-resistant tuberculosis patients in Portugal, 2000-2016
O. Oliveira (Viseu, Portugal), R. Gaio (Porto, Portugal), T. Rito (Braga, Portugal), M. Correia-Neves (Braga, Portugal), R. Duarte (Porto, Portugal)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Ready steady spit: A community based screening for lung tuberculosis amongst high-risk groups in Aalborg, Denmark
S. Shakar (Aalborg, Denmark), N. Stærke (Aarhus, Denmark), M. Christensen (Aalborg, Denmark), U. Weinreich (Aalborg, Denmark)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Preliminary evaluation of serial interferon-gamma releasing assay testing in NSCLC patients treated with immune checkpoint inhibitors
K. Fujita (Kyoto, Japan), Y. Yamamoto (Kyoto, Japan), O. Kanai (Kyoto, Japan), M. Okamura (Kyoto, Japan), K. Nakatani (Kyoto, Japan), T. Mio (Kyoto, Japan)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Genomic factors associated with katG-S315T in Mycobacterium tuberculosis clinical isolates in Vietnam
N. Hang (Hanoi, Vietnam), M. Hijikata (Tokyo, Japan), S. Maeda (Hokkaido, Japan), A. Miyabayashi (Tokyo, Japan), S. Seto (Tokyo, Japan), N. Diem (Da Nang, Vietnam), N. Yen (Da Nang, Vietnam), P. Thuong (Hanoi, Vietnam), H. Huan (Hanoi, Vietnam), N. Hoang (Hanoi, Vietnam), S. Mitarai (Tokyo, Japan), S. Kato (Tokyo, Japan), N. Keicho (Tokyo, Japan)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
The use of the lytic D29 mycobacteriophages for accelerated determination of the drug sensitivity of tuberculosis mycobacteria to first and second-line anti-TB drugs in clinical isolates obtained after initial cultivation
M. Vladimirsky (Moscow, Russian Federation), M. Lapenkova (Moscow, Russian Federation), Y. Alyapkina (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), G. Arustamova (Moscow, Russian Federation), P. Philippov (Moscow, Russian Federation)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Individualising treatment for tuberculosis: what has whole genome sequencing taught us so far?
D. Cirillo (Milano (MI), Italy)
WebcastSlide presentation
WebcastSlide presentation
The cost of treatment of tuberculosis in children of Belarus
L. Gorbach (Minsk, Belarus)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Risk of tuberculosis in pediatric patients treated with biological agents
P. Asfuroglu (ANKARA, Turkey), T. Ramasli Gursoy (ANKARA, Turkey), Z. Onay (ANKARA, Turkey), T. Sismanlar Eyuboglu (ANKARA, Turkey), E. Sunar Yayla (ANKARA, Turkey), A. Aslan (ANKARA, Turkey), S. Bakkaloglu Ezgu (ANKARA, Turkey), H. Soylemezoglu (ANKARA, Turkey), N. Buyan (ANKARA, Turkey)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Higher adverse drug reactions but better completion rate of twelve-dose weekly rifapentine plus isoniazid comparing with nine-month daily isoniazid for latent tuberculosis infection among patients under maintenance dialysis
S. Lin (Taipei, Taiwan), P. Wang (Taipei, Taiwan), J. Feng (Taipei, Taiwan), C. Shu (Taipei, Taiwan)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Determination of specific inflammation activity in the presence of the minimal tuberculous changes
T. Tyulkova (Moscow, Russian Federation), N. Khabibullina (Moscow, Russian Federation), S. Skornyakov (Ekaterinburg, Russian Federation), N. Chernavin (Ekaterinburg, Russian Federation), P. Chernavin (Ekaterinburg, Russian Federation)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Genomic analysis of new pre-XDR/XDR cluster of Mycobacterium tuberculosis Beijing genotype emerging in Russia
I. Mokrousov (St. Petersburg, Russian Federation), V. Sinkov (Irkutsk, Russian Federation), P. Khromova (Irkutsk, Russian Federation), A. Gerasimova (St. Petersburg, Russian Federation), E. Chernyaeva (St. Petersburg, Russian Federation), N. Solovieva (St. Petersburg, Russian Federation)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Chemotherapy outcome of pulmonary tuberculosis with mutations in the FN1 and TNXB genes
K. Samsonov (Omsk, Russian Federation), A. Mordyk (Moscow, Russian Federation)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
How important is work as a risk for lung infections? A story of tuberculosis and pneumonia
N. Naidoo (Durban, South Africa)
WebcastSlide presentation
WebcastSlide presentation
Establishing new treatments: the role of RCTs
L. Guglielmetti (Paris, France)
WebcastSlide presentation
WebcastSlide presentation
Diagnostic tests: what are the questions and what do we know so far?
M. Ruhwald (Copenhagen, Denmark)
WebcastSlide presentation
WebcastSlide presentation
Modelling: hot spots and targeted contacts
R. Houben (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Overview of WHO global emergencies
R. Duarte (Porto, Portugal)
WebcastSlide presentation
WebcastSlide presentation
Case presentation: A fatal endobronchial mucormycosis mimicking as endobronchial tuberculosis
H. Nam (Incheon, Republic of Korea)
PDF journal article, handout or slidesWebcast
PDF journal article, handout or slidesWebcast
Managing difficult cases from the Russian Federation and beyond: an interactive session
S. Borisov (Moscow, Russian Federation)
WebcastSlide presentation
WebcastSlide presentation
Research and clinical trial needs and the challenges associated with recommending pan-oral regimens: the Latin-American and African perspective
G. Perez Mendoza (Las Palmas, Spain)
WebcastSlide presentation
WebcastSlide presentation
Similarities and differences among existing guidelines
G. Sotgiu (Porto Torres (SS), Italy)
WebcastSlide presentation
WebcastSlide presentation
The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations
G. Migliori (Varese (VA), Italy)
WebcastSlide presentation
WebcastSlide presentation
Non-tuberculosis mycobacterium related bronchiectasis is associated with oral commensals in the lower airway
I. Sulaiman (NYC, United States of America), B. Wu (NYC, United States of America), J. Tsay (NYC, United States of America), Y. Li (NYC, United States of America), A. Scott (NYC, United States of America), A. Basavaraj (NYC, United States of America), J. Bessich (NYC, United States of America), G. Michaud (NYC, United States of America), S. Rafeq (NYC, United States of America), J. Donington (NYC, United States of America), R. Condos (NYC, United States of America), D. Kamelhar (NYC, United States of America), D. Addrizzo-Harris (NYC, United States of America), L. Segal (NYC, United States of America)
Congress or journal article abstractWebcast
Congress or journal article abstractWebcast
Moving tuberculosis vaccines from theory to practice
P. Andersen (Copenhagen, Denmark)
WebcastSlide presentation
WebcastSlide presentation
Respiratory infections in children: from respiratory syncytial virus to tuberculosis
M. Proesmans (Leuven, Belgium)
WebcastSlide presentation
WebcastSlide presentation
Impact of the introduction of a paediatric ‘virtual TB clinic’
L. Turnbull (Manchester, United Kingdom), F. Child (Manchester, United Kingdom)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Do higher quantitative interferon gamma release assay or tuberculin skin test results help to predict incident tuberculosis? Data from the UK PREDICT study
R. Gupta (London, United Kingdom), M. Lipman (London, United Kingdom), C. Jackson (London, United Kingdom), A. Sitch (Birmingham, United Kingdom), J. Southern (London, United Kingdom), F. Drobniewski (London, United Kingdom), J. Deeks (Birmingham, United Kingdom), C. Tsou (London, United Kingdom), C. Griffiths (London, United Kingdom), J. Davidson (London, United Kingdom), C. Campbell (London, United Kingdom), O. Stirrup (London, United Kingdom), M. Noursadeghi (London, United Kingdom), H. Kunst (London, United Kingdom), P. Haldar (Leicester, United Kingdom), A. Lalvani (London, United Kingdom), I. Abubakar (London, United Kingdom)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Treatment of severe Mycobacterium avium complex pulmonary disease with a adjunctive amikacin and clofazimine versus standard regimen alone, a retrospective study
S. Zweijpfenning (Nijmegen, Netherlands), S. Kops (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), S. Kuipers (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Posttransplant tuberculosis in Europe – a TBnet study
B. Lange (Freiburg, Germany), S. Arend (Leiden, Netherlands), C. Armbruster (Freiburg, Germany), M. Arias-Guillén (Oviedo, Spain), M. Bakker (Rotterdam, Netherlands), C. Berastegui (Barcelona, Spain), M. Babiker (Coventry, United Kingdom), R. Charif (London, United Kingdom), R. Duarte (Porto, Portugal), H. Flick (Graz, Austria), R. Hofland (Utrecht, Netherlands), J. Ismail (London, United Kingdom), N. Krishnan (Coventry, United Kingdom), D. Kniepeiss (Graz, Austria), H. Kunst (London, United Kingdom), D. Kuijpers (Leiden, Netherlands), C. Lange (Borstel, Germany), V. Lezaic (Belgrade, Republic of Serbia), I. Los Arcos (Barcelona, Spain), J. Machova (Pilsen, Czech Republic), H. Milburn (London, United Kingdom), O. Kon (London, United Kingdom), C. Osoro Suarez (Oviedo, Spain), D. Pesut (Belgrade, Republic of Serbia), A. Rahman (London, United Kingdom), T. Reischig (Pilsen, Czech Republic), A. Sanchez Montalva (Barcelona, Spain), H. Spohn (Saarbrücken, Germany), M. Stegenga (Rotterdam, Netherlands), A. De Vries (Leiden, Netherlands), D. Wagner (Freiburg, Germany), R. Wobser (Freiburg, Germany), M. Sester (Saarbrücken, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Long-term incidence of tuberculosis among migrants according to migrant status: a cohort study
. Kristensen (Copenhagen, Denmark), T. Lillebaek (Copenhagen, Denmark), J. Petersen (Copenhagen, Denmark), S. Hargreaves (London, United Kingdom), L. Nellums (London, United Kingdom), J. Friedland (London, United Kingdom), P. Andersen (Copenhagen, Denmark), P. Ravn (Copenhagen, Denmark), M. Noerredam (Copenhagen, Denmark)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up.
M. Arias Guillen (Oviedo, Spain), R. De Francisco (Oviedo, Spain), S. Riestra-Menéndez (Oviedo, Spain), G. Muñiz-Albaiceta (Oviedo, Spain), M. González-Budiño (Oviedo, Spain), M. García-Clemente (Oviedo, Spain), C. Del Busto (Oviedo, Spain), M. Santibáñez-Margüello (Santander, Spain), A. Castaño-García (Oviedo, Spain), S. Martínez-González (Oviedo, Spain), C. Huidobro (Oviedo, Spain), L. Pérez-González (Oviedo, Spain), I. Ruiz-Alvarez (Oviedo, Spain), J. Herrero-Huertas (Oviedo, Spain), P. Ugarriza (Oviedo, Spain), V. Jiménez-Beltrán (Oviedo, Spain), P. Flórez-Díez (Oviedo, Spain), N. Rodríguez (Oviedo, Spain), C. Bailón (Oviedo, Spain), S. Gómez-Mañas (Oviedo, Spain), A. Losada-Dieguez (Oviedo, Spain), P. Escalante (Ro,MN, United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area
S. Rosales-Klintz (Solna, Sweden), M. Van Der Werf (Solna, Sweden)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Randomised controlled double blind dose-escalation infant trial of the live-attenuated Mycobacterium tuberculosis vaccine MTBVAC
M. Tameris (Cape Town, South Africa)
WebcastSlide presentation
WebcastSlide presentation
Latest insights and challenges in tuberculosis vaccine development
H. Mcshane (Oxford (Oxfordshire), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Challenges in the prevention, diagnosis, and treatment of tuberculosis in children
J. Furin (Strongsville, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Management and treatment of multidrug-resistant tuberculosis
C. Lange (Borstel, Germany)
WebcastSlide presentation
WebcastSlide presentation
Tobacco smoking as a risk factor of active tuberculosis in HIV-infected patients
E. Kulabukhova (Moscow, Russian Federation), V. Zimina (Moscow, Russian Federation), A. Kravtchenko (Moscow, Russian Federation), S. Degtyareva (Moscow, Russian Federation), E. Beloborodova (Moscow, Russian Federation), A. Peregudova (Moscow, Russian Federation)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan
A. Takaki (Tokyo, Japan), A. Aono (Tokyo, Japan), K. Chikamatsu (Tokyo, Japan), Y. Igarashi (Tokyo, Japan), Y. Shimomura (Tokyo, Japan), Y. Murase (Tokyo, Japan), H. Yoshida (Osaka, Japan), . Tamura (Osaka, Japan), T. Nagai (Osaka, Japan), Y. Morishige (Tokyo, Japan), H. Yamada (Tokyo, Japan), S. Mitarai (Tokyo, Japan)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study.
A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), S. Setkina (Minsk, Belarus), V. Grankov (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), V. Kralko (Minsk, Belarus), D. Klimuk (Minsk, Belarus), M. Dara (Copenhagen, Denmark)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Drug resistance-conferring mutations in Mycobacterium-tuberculosis isolated from retreated patients in Hanoi, Vietnam
N. Thi Le Hang (Hanoi, Vietnam), M. Hijikata (Tokyo, Japan), S. Maeda (Hokkaido, Japan), P. Huu Thuong (Hanoi, Vietnam), H. Van Huan (Hanoi, Vietnam), N. Phuong Hoang (Hanoi, Vietnam), I. Matsushita (Tokyo, Japan), N. Keicho (Tokyo, Japan)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Results of traditional and new regimens of MDR/XDR TB treatment: cohort analysis
S. Borisov (Moscow, Russian Federation), A. Filippov (Moscow, Russian Federation), I. Danilova (Moscow, Russian Federation), S. Kosenkov (Moscow, Russian Federation)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Comorbidity clusters associated with length of hospital stay in patients with tuberculosis
F. Baty (St. Gallen, Switzerland), O. Schoch (St. Gallen, Switzerland), S. Tonko (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
High-dose rifampicin in tuberculosis: experiences from a Dutch tuberculosis centre
C. Seijger (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), I. Bergsma (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), S. Kuijpers (Nijmegen, Netherlands), L. Te Brake (Nijmegen, Netherlands), R. Van Crevel (Nijmegen, Netherlands), R. Aarnoutse (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
People-Centred Care in Tuberculosis - Advocacy, community and achieving quality care
P. Sommerfeld (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
C. Mitnick (Boston, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies?
C. Hewison (Paris, France)
WebcastSlide presentation
WebcastSlide presentation
Integration of care pathways for HIV-tuberculosis coinfection: a public health agenda
F. Blanc (Nantes Cedex 1, France)
WebcastSlide presentation
WebcastSlide presentation
Innovative tools for diagnosis and prevention of paediatric tuberculosis
M. Bonnet (Genève, Switzerland)
WebcastSlide presentation
WebcastSlide presentation